B. Schüll

发表

Effective Combination Chemotherapy with Bimonthly Docetaxel and Cisplatin with or without Hematopoietic Growth Factor Support in Patients with Advanced Gastroesophageal Cancer

W. Scheithauer, K. Schmid, M. Raderer, 2003, Oncology.

Effective combination chemotherapy with paclitaxel and cisplatin with or without human granulocyte colony-stimulating factor and/or erythropoietin in patients with advanced gastric cancer

W. Scheithauer, B. Schneeweiss, M. Raderer, 2002, British Journal of Cancer.

Effective treatment of oxaliplatin-induced cumulative polyneuropathy with alpha-lipoic acid.

W. Scheithauer, G. Kornek, B. Schuell, 2002, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Biweekly high-dose gemcitabine alone or in combination with capecitabine in patients with metastatic pancreatic adenocarcinoma: a randomized phase II trial.

W. Scheithauer, B. Schneeweiss, K. Schmid, 2003, Annals of oncology : official journal of the European Society for Medical Oncology.

Second-Line Treatment of Advanced Colorectal Cancer with a Biweekly Oxaliplatin plus Irinotecan Combination Regimen

W. Scheithauer, B. Schneeweiss, K. Schmid, 2002, Oncology Research and Treatment.

Capecitabine as Salvage Therapy for a Breast Cancer Patient with Extensive Liver Metastases and Associated Impairment of Liver Function

W. Scheithauer, G. Kornek, B. Schuell, 2003, Oncology Research and Treatment.

Randomized multicenter phase II trial of two different schedules of capecitabine plus oxaliplatin as first-line treatment in advanced colorectal cancer.

W. Scheithauer, B. Schneeweiss, K. Schmid, 2003, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Impact of hemoglobin level and use of recombinant erythropoietin on efficacy of preoperative chemoradiation therapy for squamous cell carcinoma of the oral cavity and oropharynx.

F. Watzinger, W. Millesi, R. Lavey, 2001, International journal of radiation oncology, biology, physics.

Intermittent weekly high-dose capecitabine in combination with oxaliplatin: a phase I/II study in first-line treatment of patients with advanced colorectal cancer.

W. Scheithauer, K. Schmid, M. Raderer, 2002, Annals of oncology : official journal of the European Society for Medical Oncology.

Randomized multicenter phase II trial of oxaliplatin plus irinotecan versus raltitrexed as first-line treatment in advanced colorectal cancer.

W. Scheithauer, B. Schneeweiss, M. Raderer, 2002, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Mitoxantrone and cisplatin in recurrent and/or metastatic salivary gland malignancies

W. Scheithauer, M. Burian, G. Kornek, 2002, Anti-cancer drugs.

Hepatic arterial chemotherapy of liver metastases from colorectal cancer: Treatment results, limitations and future aspects

W. Scheithauer, B. Schuell, B. Schüll, 2002, European Surgery.

Irinotecan plus raltitrexed vs raltitrexed alone in patients with gemcitabine-pretreated advanced pancreatic adenocarcinoma

W. Scheithauer, B. Schneeweiss, K. Schmid, 2003, British Journal of Cancer.

Treatment of advanced breast cancer with docetaxel and gemcitabine with and without human granulocyte colony-stimulating factor.

W. Scheithauer, W. Kwasny, M. Raderer, 2002, Clinical cancer research : an official journal of the American Association for Cancer Research.

Treatment of Advanced Hepatocellular Carcinoma with Biweekly High-Dose Gemcitabine

W. Scheithauer, M. Raderer, G. Kornek, 2001, Oncology.

Second-Line Treatment of Advanced Gastric Cancer with Oxaliplatin plus Raltitrexed

W. Scheithauer, K. Schmid, M. Raderer, 2003, Oncology Research and Treatment.

10 Impact of hemoglobin (Hgb) level and use of recombinant human erythropoietin (r-HuEPO) on response to neoadjuvant chemoradiation therapy, tumor control, and survival in patients with oral or oropharyngeal squamous cell carcinoma (SCCA)

W. Millesi, R. Lavey, F. Wanschitz, 1999 .